Elimination of Schistosoma mansoni in infected mice by slow release of artemisone
The current treatment of schistosomiasis is based on the anti-helminthic drug praziquantel (PZQ). PZQ affects only the adult stages of schistosomes. In addition, resistance to PZQ is emerging. We suggest a drug, which could serve as a potential alternative or complement to PZQ, and as a means of tre...
Main Authors: | Daniel Gold, Mohammed Alian, Avraham Domb, Yara Karawani, Maysa Jbarien, Jacques Chollet, Richard K. Haynes, Ho Ning Wong, Viola Buchholz, Andreas Greiner, Jacob Golenser |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221132071730012X |
Similar Items
-
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
by: Jacob Golenser, et al.
Published: (2020-06-01) -
Artemisone effective against murine cerebral malaria
by: Waknine-Grinberg Judith H, et al.
Published: (2010-08-01) -
Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
by: Johanna Zech, et al.
Published: (2020-06-01) -
<it>Schistosoma mansoni </it>infection reduces the incidence of murine cerebral malaria
by: Heyfets Alina, et al.
Published: (2010-01-01) -
Ultrastructural alterations in adult Schistosoma mansoni caused by artemether
by: Shuhua Xiao, et al.
Published: (2002-07-01)